JVMTX
Price
$29.31
Change
-$0.22 (-0.75%)
Updated
Aug 15 closing price
Net Assets
23.59B
SMVZX
Price
$12.65
Change
-$0.08 (-0.63%)
Updated
Aug 15 closing price
Net Assets
1.1B
Interact to see
Advertisement

JVMTX vs SMVZX

Header iconJVMTX vs SMVZX Comparison
Open Charts JVMTX vs SMVZXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$29.31
Change-$0.22 (-0.75%)
VolumeN/A
Net Assets23.59B
Virtus Ceredex Mid-Cap Value Equity R6
Price$12.65
Change-$0.08 (-0.63%)
VolumeN/A
Net Assets1.1B
JVMTX vs SMVZX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVMTX vs. SMVZX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and SMVZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.6B vs. SMVZX (1.1B). SMVZX pays higher dividends than JVMTX: SMVZX (1.13) vs JVMTX (0.64). JVMTX was incepted earlier than SMVZX: JVMTX (12 years) vs SMVZX (11 years). JVMTX (1.11) is less costly to investors than SMVZX (0.88). SMVZX is a more actively managed with annual turnover of: 141.00 vs. JVMTX (49.00). JVMTX has a lower initial minimum investment than SMVZX: JVMTX (0) vs SMVZX (2500000). JVMTX annual gain was more profitable for investors over the last year : 0.62 vs. SMVZX (0.47). JVMTX return over 5 years is better than : 49.36 vs. SMVZX (24.20).
JVMTXSMVZXJVMTX / SMVZX
Total Expense Ratio1.000.79127%
Annual Report Gross Expense Ratio1.110.88126%
Fund Existence12 years11 years-
Gain YTD8.9194.805186%
Front LoadN/AN/A-
Min. Initial Investment02500000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.6B1.1B2,151%
Annual Yield % from dividends0.641.1357%
Returns for 1 year0.620.47133%
Returns for 3 years11.5813.2088%
Returns for 5 years49.3624.20204%
Returns for 10 years43.955.26836%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTHP0.280.02
+8.35%
Guided Therapeutics, Inc.
FBSFF18.00N/A
N/A
Fabasoft AG
HMNKF42.20N/A
N/A
HMS Networks AB
OUKPF10.56N/A
N/A
Metso OYJ
LGNC221.00N/A
N/A
Logan Clay Products Co.